The University of Chicago Header Logo

Connection

Kenneth Gordon to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Kenneth Gordon has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Kenneth Gordon
Connection Strength
0.064
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity. J Dermatolog Treat. 2007; 18(1):13-8.
    View in: PubMed
    Score: 0.064
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.